- call +1-201-465-4211
- email sales@mrinsights.biz
The endocrine system is an integrated network that consists of various glands located throughout the body.
Scope of the Report:
This report studies the Endocrine Testing market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Endocrine Testing market by product type and applications/end industries.
Growing incidences of endocrine disorders such as hyperthyroidism and adrenal insufficiency is predicted to boost the demand for endocrine testing.
The global Endocrine Testing market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Endocrine Testing.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Abbott Laboratories
AdnaGen
Beckman Coulter/Danaher
Biomedical Diagnostics
BioMerieux
Bio-Rad
Dako
DiaSorin
Eiken
Fujirebio
Instrumentation Laboratory
Kyowa Medex
Matritech
Ortho-Clinical Diagnostics
Roche
Siemens
Sysmex
Thermo Fisher
Tosoh
Wako
Wallac/PE
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Tandem Mass Spectrometry
Immunoassay
Market Segment by Applications, can be divided into
Hospitals
Commercial Laboratories
Ambulatory Care Centres
Other Setting
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Endocrine Testing Market Overview
1.1 Product Overview and Scope of Endocrine Testing
1.2 Classification of Endocrine Testing by Types
1.2.1 Global Endocrine Testing Revenue Comparison by Types (2017-2023)
1.2.2 Global Endocrine Testing Revenue Market Share by Types in 2017
1.2.3 Tandem Mass Spectrometry
1.2.4 Immunoassay
1.3 Global Endocrine Testing Market by Application
1.3.1 Global Endocrine Testing Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 Commercial Laboratories
1.3.4 Ambulatory Care Centres
1.3.5 Other Setting
1.4 Global Endocrine Testing Market by Regions
1.4.1 Global Endocrine Testing Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Endocrine Testing Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Endocrine Testing Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Endocrine Testing Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Endocrine Testing Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Endocrine Testing Status and Prospect (2013-2023)
1.5 Global Market Size of Endocrine Testing (2013-2023)
2 Manufacturers Profiles
2.1 Abbott Laboratories
2.1.1 Business Overview
2.1.2 Endocrine Testing Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Abbott Laboratories Endocrine Testing Revenue, Gross Margin and Market Share (2016-2017)
2.2 AdnaGen
2.2.1 Business Overview
2.2.2 Endocrine Testing Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 AdnaGen Endocrine Testing Revenue, Gross Margin and Market Share (2016-2017)
2.3 Beckman Coulter/Danaher
2.3.1 Business Overview
2.3.2 Endocrine Testing Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Beckman Coulter/Danaher Endocrine Testing Revenue, Gross Margin and Market Share (2016-2017)
2.4 Biomedical Diagnostics
2.4.1 Business Overview
2.4.2 Endocrine Testing Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Biomedical Diagnostics Endocrine Testing Revenue, Gross Margin and Market Share (2016-2017)
2.5 BioMerieux
2.5.1 Business Overview
2.5.2 Endocrine Testing Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 BioMerieux Endocrine Testing Revenue, Gross Margin and Market Share (2016-2017)
2.6 Bio-Rad
2.6.1 Business Overview
2.6.2 Endocrine Testing Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Bio-Rad Endocrine Testing Revenue, Gross Margin and Market Share (2016-2017)
2.7 Dako
2.7.1 Business Overview
2.7.2 Endocrine Testing Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Dako Endocrine Testing Revenue, Gross Margin and Market Share (2016-2017)
2.8 DiaSorin
2.8.1 Business Overview
2.8.2 Endocrine Testing Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 DiaSorin Endocrine Testing Revenue, Gross Margin and Market Share (2016-2017)
2.9 Eiken
2.9.1 Business Overview
2.9.2 Endocrine Testing Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Eiken Endocrine Testing Revenue, Gross Margin and Market Share (2016-2017)
2.10 Fujirebio
2.10.1 Business Overview
2.10.2 Endocrine Testing Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Fujirebio Endocrine Testing Revenue, Gross Margin and Market Share (2016-2017)
2.11 Instrumentation Laboratory
2.11.1 Business Overview
2.11.2 Endocrine Testing Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Instrumentation Laboratory Endocrine Testing Revenue, Gross Margin and Market Share (2016-2017)
2.12 Kyowa Medex
2.12.1 Business Overview
2.12.2 Endocrine Testing Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Kyowa Medex Endocrine Testing Revenue, Gross Margin and Market Share (2016-2017)
2.13 Matritech
2.13.1 Business Overview
2.13.2 Endocrine Testing Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Matritech Endocrine Testing Revenue, Gross Margin and Market Share (2016-2017)
2.14 Ortho-Clinical Diagnostics
2.14.1 Business Overview
2.14.2 Endocrine Testing Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Ortho-Clinical Diagnostics Endocrine Testing Revenue, Gross Margin and Market Share (2016-2017)
2.15 Roche
2.15.1 Business Overview
2.15.2 Endocrine Testing Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Roche Endocrine Testing Revenue, Gross Margin and Market Share (2016-2017)
2.16 Siemens
2.16.1 Business Overview
2.16.2 Endocrine Testing Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Siemens Endocrine Testing Revenue, Gross Margin and Market Share (2016-2017)
2.17 Sysmex
2.17.1 Business Overview
2.17.2 Endocrine Testing Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Sysmex Endocrine Testing Revenue, Gross Margin and Market Share (2016-2017)
2.18 Thermo Fisher
2.18.1 Business Overview
2.18.2 Endocrine Testing Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Thermo Fisher Endocrine Testing Revenue, Gross Margin and Market Share (2016-2017)
2.19 Tosoh
2.19.1 Business Overview
2.19.2 Endocrine Testing Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Tosoh Endocrine Testing Revenue, Gross Margin and Market Share (2016-2017)
2.20 Wako
2.20.1 Business Overview
2.20.2 Endocrine Testing Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 Wako Endocrine Testing Revenue, Gross Margin and Market Share (2016-2017)
2.21 Wallac/PE
2.21.1 Business Overview
2.2.2 Endocrine Testing Type and Applications
2.21.2.1 Product A
2.21.2.2 Product B
2.21.3 Wallac/PE Endocrine Testing Revenue, Gross Margin and Market Share (2016-2017)
3 Global Endocrine Testing Market Competition, by Players
3.1 Global Endocrine Testing Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Endocrine Testing Players Market Share
3.2.2 Top 10 Endocrine Testing Players Market Share
3.3 Market Competition Trend
4 Global Endocrine Testing Market Size by Regions
4.1 Global Endocrine Testing Revenue and Market Share by Regions
4.2 North America Endocrine Testing Revenue and Growth Rate (2013-2018)
4.3 Europe Endocrine Testing Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Endocrine Testing Revenue and Growth Rate (2013-2018)
4.5 South America Endocrine Testing Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Endocrine Testing Revenue and Growth Rate (2013-2018)
5 North America Endocrine Testing Revenue by Countries
5.1 North America Endocrine Testing Revenue by Countries (2013-2018)
5.2 USA Endocrine Testing Revenue and Growth Rate (2013-2018)
5.3 Canada Endocrine Testing Revenue and Growth Rate (2013-2018)
5.4 Mexico Endocrine Testing Revenue and Growth Rate (2013-2018)
6 Europe Endocrine Testing Revenue by Countries
6.1 Europe Endocrine Testing Revenue by Countries (2013-2018)
6.2 Germany Endocrine Testing Revenue and Growth Rate (2013-2018)
6.3 UK Endocrine Testing Revenue and Growth Rate (2013-2018)
6.4 France Endocrine Testing Revenue and Growth Rate (2013-2018)
6.5 Russia Endocrine Testing Revenue and Growth Rate (2013-2018)
6.6 Italy Endocrine Testing Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Endocrine Testing Revenue by Countries
7.1 Asia-Pacific Endocrine Testing Revenue by Countries (2013-2018)
7.2 China Endocrine Testing Revenue and Growth Rate (2013-2018)
7.3 Japan Endocrine Testing Revenue and Growth Rate (2013-2018)
7.4 Korea Endocrine Testing Revenue and Growth Rate (2013-2018)
7.5 India Endocrine Testing Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Endocrine Testing Revenue and Growth Rate (2013-2018)
8 South America Endocrine Testing Revenue by Countries
8.1 South America Endocrine Testing Revenue by Countries (2013-2018)
8.2 Brazil Endocrine Testing Revenue and Growth Rate (2013-2018)
8.3 Argentina Endocrine Testing Revenue and Growth Rate (2013-2018)
8.4 Colombia Endocrine Testing Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Endocrine Testing by Countries
9.1 Middle East and Africa Endocrine Testing Revenue by Countries (2013-2018)
9.2 Saudi Arabia Endocrine Testing Revenue and Growth Rate (2013-2018)
9.3 UAE Endocrine Testing Revenue and Growth Rate (2013-2018)
9.4 Egypt Endocrine Testing Revenue and Growth Rate (2013-2018)
9.5 Nigeria Endocrine Testing Revenue and Growth Rate (2013-2018)
9.6 South Africa Endocrine Testing Revenue and Growth Rate (2013-2018)
10 Global Endocrine Testing Market Segment by Type
10.1 Global Endocrine Testing Revenue and Market Share by Type (2013-2018)
10.2 Global Endocrine Testing Market Forecast by Type (2018-2023)
10.3 Tandem Mass Spectrometry Revenue Growth Rate (2013-2023)
10.4 Immunoassay Revenue Growth Rate (2013-2023)
11 Global Endocrine Testing Market Segment by Application
11.1 Global Endocrine Testing Revenue Market Share by Application (2013-2018)
11.2 Endocrine Testing Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Commercial Laboratories Revenue Growth (2013-2018)
11.5 Ambulatory Care Centres Revenue Growth (2013-2018)
11.6 Other Setting Revenue Growth (2013-2018)
12 Global Endocrine Testing Market Size Forecast (2018-2023)
12.1 Global Endocrine Testing Market Size Forecast (2018-2023)
12.2 Global Endocrine Testing Market Forecast by Regions (2018-2023)
12.3 North America Endocrine Testing Revenue Market Forecast (2018-2023)
12.4 Europe Endocrine Testing Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Endocrine Testing Revenue Market Forecast (2018-2023)
12.6 South America Endocrine Testing Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Endocrine Testing Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Endocrine Testing Picture
Table Product Specifications of Endocrine Testing
Table Global Endocrine Testing and Revenue (Million USD) Market Split by Product Type
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
